Perflutren Protein Type A and Pramipexole Extended-Release Tablets
Determining the interaction of Perflutren Protein Type A and Pramipexole Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: perflutren
Brand name: Definity, Optison
Synonyms: Perflutren, Perflutren Lipid Microspheres
Generic Name: pramipexole
Brand name: Mirapex, Mirapex ER
Synonyms: Pramipexole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Perflutren Protein Type A-Pramipexole Tablets
- Perflutren Protein Type A-Pramlintide
- Perflutren Protein Type A-Pramlintide Acetate
- Perflutren Protein Type A-Pramlintide Subcutaneous
- Perflutren Protein Type A-Pramosone
- Perflutren Protein Type A-Pramosone Cream
- Pramipexole Extended-Release Tablets-Perflutren protein type a microsphere Intravenous
- Pramipexole Extended-Release Tablets-Perforomist
- Pramipexole Extended-Release Tablets-Perforomist, Symbicort
- Pramipexole Extended-Release Tablets-Pergolide
- Pramipexole Extended-Release Tablets-Pergonal
- Pramipexole Extended-Release Tablets-Peri-Colace